
About Vanguard Diagnostics
Vanguard Diagnostics is a Healthcare company based in Delhi (India) founded in 2015. Medical diagnostic reagents and devices are manufactured and marketed. The company has 28 employees. Its chief executive, as recorded, is Veena Kohli. Its Indian entity Vanguard Diagnostics Private Limited reported revenue of βΉ20.87 Cr. Vanguard Diagnostics offers products and services including Typhoid RT PCR, Hematology Reagents, Hematology Controls, Biochemistry Reagents, and Immunology Diagnostic Tests. Its focus areas include Diversified Medical Devices.
Company details
Vanguard was established in 2015 in Delhi, India, within the medical diagnostics sector. Reagents and devices for diagnostic purposes are produced and distributed by the company. Operations center on the development and commercialization of these products to support healthcare testing needs. The firm is led by CEO MD Veena Kohli, with activities primarily based in India.
- Headquarters Delhi, India
- Employees 28
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website vanguarddiagnostics.com
- Social LinkedIn
- Legal Name Vanguard Diagnostics Private Limited
- Date of Incorporation 02 Feb, 2015
- Jurisdiction Delhi, India
- Annual Revenue₹20.87 Cr
FY 2025 · -18% YoY
- Net Profit₹53.7 Lakh
FY 2025 · 3% margin
- EBITDA₹1.80 Cr
FY 2025 · 9% margin
- Employee Count28
Associated legal entities of Vanguard Diagnostics
Vanguard Diagnostics operates through Vanguard Diagnostics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vanguard Diagnostics Private Limited CIN U33110DL2015PTC276193 | Active | 02 Feb 2015 | New Delhi, Delhi | ₹20.9 Cr | 28 | 4 | View details |
Products & Services of Vanguard Diagnostics
Vanguard Diagnostics offers a comprehensive portfolio of products and services, including Typhoid RT PCR, Hematology Reagents, Hematology Controls, Biochemistry Reagents, and Immunology Diagnostic Tests.
RT-PCR test for detecting Salmonella typhi and paratyphi in blood samples.
Reagents for blood analysis in hematology laboratories worldwide.
Controls for ensuring accuracy in hematology diagnostic procedures.
Reagents used for biochemical testing in clinical settings.
Tests for detecting immune-related disorders and infections.
Tests for rapid detection of COVID-19 in human samples.
Board of directors of Vanguard Diagnostics Private Limited (Vanguard Diagnostics)
Vanguard Diagnostics Private Limited is the primary company behind Vanguard Diagnostics. The board of Vanguard Diagnostics Private Limited currently have 4 directors; the longest-serving is Anil Kumar Virmani, appointed in 2015. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anil Kumar Virmani DIN 07073933 | Director | 02 Feb 2015 | 11 yrs 9 mo | Vanguard Diagnostics Private Limited |
| Rahul Thakur DIN 07073930 | Director | 08 Mar 2015 | 11 yrs 8 mo | Vanguard Diagnostics Private Limited |
| Ram Pramod Tiwari DIN 01974534 | Director | 26 May 2015 | 11 yrs 5 mo | Vanguard Diagnostics Private Limited |
| Veena Kohli DIN 07377795 | Director | 19 Oct 2015 | 11 yrs 1 mo | Vanguard Diagnostics Private Limited |
People of Vanguard Diagnostics
1 people are tracked at Vanguard Diagnostics (1 in leadership); the tracked headcount is 28.
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership |
Complete people profiles for Vanguard Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vanguard Diagnostics
Figures of Vanguard Diagnostics Private Limited, the primary company behind Vanguard Diagnostics, for FY 2025. Revenue was ₹20.87 Cr (-18% year on year). Net profit was ₹53.7 Lakh (3% margin). EBITDA was ₹1.80 Cr (9% margin). Revenue has grown at a compounded annual rate of -1% over three years and +16% over five years.
- ₹20.87 CrRevenue · FY 2025 · -18% YoY
- ₹53.7 LakhNet profit · 3% margin
- ₹1.80 CrEBITDA · 9% margin
- ₹2.17 CrPaid-up capital
- 28Employees (provident fund records)
- -1%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vanguard Diagnostics Private Limited are on its company page.
Detailed financial statements for Vanguard Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Vanguard Diagnostics
The website of Vanguard Diagnostics (vanguarddiagnostics.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 26.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vanguard Diagnostics
Vanguard Diagnostics was founded in 2015.
Vanguard Diagnostics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Veena Kohli is the CEO of Vanguard Diagnostics, as recorded in our data.
Vanguard Diagnostics has 28 employees.
The primary company behind Vanguard Diagnostics, Vanguard Diagnostics Private Limited, reported revenue of βΉ20.87 Cr for FY 2025, down 18% year on year.
Vanguard was established in 2015 in Delhi, India, within the medical diagnostics sector. Reagents and devices for diagnostic purposes are produced and distributed by the company. Operations center on the development and commercialization of these products to support healthcare testing needs. The firm is led by CEO MD Veena Kohli, with activities primarily based in India.
Vanguard Diagnostics offers Typhoid RT PCR, Hematology Reagents, Hematology Controls, Biochemistry Reagents, and 2 more products and services.
Vanguard Diagnostics operates through Vanguard Diagnostics Private Limited.
The legal entities of Vanguard Diagnostics currently have 4 directors, including Ram Pramod Tiwari, Veena Kohli, Anil Kumar Virmani and others.